"Misha Kapushesky, founder of Cambridge-based Genestack, speaking to
Cambridge Business magazine, said of the increasingly available dataset: "As a proportion of genomics and sequencing the production costs are going down - it's getting cheaper - and data management is going up. The progression of this technology goes in leaps and bounds. The last leap was six or seven years ago which was NGS - next-generation sequencing. That allowed David Cameron to announce the 100,000 Genome Project." This project meant 100,000 UK patients with cancer and rare diseases had their entire genome decoded, leading to targeted therapies which could make chemotherapy "a thing of the past"."
Read full article here